Analyst consensus rating
USANA Health Sciences Analyst Rating: none
USNA is rated none by 1 analysts with a $25.00 target. As of 2026-08-28.
Direct answer
USANA Health Sciences's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $25.00.
Forecast evidence checked August 28, 2026.
Get free USANA Health Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.10
- Average price target
- $25.00
- High price target
- $25.00
- Low price target
- $25.00
- Low target gap
- +77.3%
- Target upside
- +77.3%
- High target gap
- +77.3%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 28, 2026
- Valid through
- September 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for USANA Health Sciences?
USANA Health Sciences has a verified none consensus. The same dataset has an average price target of $25.00.
How far are USANA Health Sciences's low and high targets from the recorded price?
The low target implies +77.3%, while the high target implies +77.3%.
How many analysts are included in USANA Health Sciences's consensus?
The verified consensus includes 1 analysts.
How is USANA Health Sciences's target upside or downside calculated?
The average target of $25.00 is divided by the recorded price of $14.10, then one is subtracted to produce +77.3%. This does not guarantee a future return.
When was USANA Health Sciences's analyst forecast verified?
The data was verified on 2026-08-28. The dataset is valid through 2026-09-04.